Skip to main content

Breast Cancer

Edited by: Dr Marc Lippman

The Breast Cancer Collection is an invitation-only sister title of the Springer subscription journal, Breast Cancer Research and Treatment (BREA).

Invited submissions should choose the Breast Cancer Collection during submission, and include the invitation letter from Dr Lippman in their SpringerPlus cover letter.

For more information about how you can be considered for the Breast Cancer Collection, please speak to the editorial team at BREA.

 

Collection Articles:

Page 2 of 4

  1. As the breast cancer survivor population increases, the topic of screening these women for recurrences is increasingly relevant. In our institution, we use both breast MRI and mammography in the surveillance o...

    Authors: Chana Weinstock, Cristina Campassi, Olga Goloubeva, Kathleen Wooten, Susan Kesmodel, Emily Bellevance, Steven Feigenberg, Olga Ioffe and Katherine H R Tkaczuk

    Citation: SpringerPlus 2015 4:459

    Content type: Research

    Published on:

  2. Clinical trials and epidemiological evidence have shown that combined estrogen/progestin hormone replacement therapy, but not estrogen therapy alone, increases breast cancer risk in post-menopausal women. Pre...

    Authors: Matthew T. Cook, Yayun Liang, Cynthia Besch-Williford, Sandy Goyette, Benford Mafuvadze and Salman M. Hyder

    Citation: SpringerPlus 2015 4:444

    Content type: Research

    Published on:

  3. Desmopressin (dDAVP) is a well-known peptide analog of the antidiuretic hormone vasopressin, used to prevent excessive bleeding during surgical procedures. dDAVP increases hemostatic mediators, such as the von...

    Authors: Ruth S Weinberg, Marcelo O Grecco, Gimena S Ferro, Debora J Seigelshifer, Nancy V Perroni, Francisco J Terrier, Analía Sánchez-Luceros, Esteban Maronna, Ricardo Sánchez-Marull, Isabel Frahm, Marcelo D Guthmann, Daniela Di Leo, Eduardo Spitzer, Graciela N Ciccia, Juan Garona, Marina Pifano…

    Citation: SpringerPlus 2015 4:428

    Content type: Research

    Published on:

  4. Tamoxifen is an anti-estrogenic drug that is widely used for endocrine-dependent breast cancer as adjuvant hormonal therapy, and its use has been reported to be frequently associated with high levels of serum ...

    Authors: Rena Yamazaki, Masafumi Inokuchi, Satoko Ishikawa, Subaru Myojo, Junpei Iwadare, Yukiko Bono, Yasunari Mizumoto, Mitsuhiro Nakamura, Masahiro Takakura, Takashi Iizuka, Tetsuo Ohta and Hiroshi Fujiwara

    Citation: SpringerPlus 2015 4:425

    Content type: Research

    Published on:

  5. Physical activity (PA) has a myriad of benefits for breast cancer survivors, including a reduced risk of cancer recurrence. Latinas are less physically active than are women in the general population and littl...

    Authors: Daniel C Hughes, Maribel Tirado-Gomez, Liliana Vallejo, Velda Gonzalez, Rose A Treviño-Whitaker, Gabriela Villanueva and Karen Basen-Engquist

    Citation: SpringerPlus 2015 4:416

    Content type: Research

    Published on:

  6. To evaluate the reliability of the Attitudes to Randomized Trial Questionnaire (ARTQ) in measuring perceptions of cancer clinical trials in a predominantly African American (AA) sample in South Carolina (SC).

    Authors: Marvella E Ford, Wei Wei, Leslie A Moore, Dana R Burshell, Kimberly Cannady, Franshawn Mack, Nnadozie Ezerioha, Kelley Ercole and Elizabeth Garrett-Mayer

    Citation: SpringerPlus 2015 4:411

    Content type: Short Report

    Published on:

  7. Febrile neutropenia (FN) is a major dose-limiting toxicity of cancer chemotherapy resulting in considerable morbidity, mortality, and cost. This study evaluated the time course of neutropenic events and patter...

    Authors: Eva Culakova, Marek S Poniewierski, Debra A Wolff, David C Dale, Jeffrey Crawford and Gary H Lyman

    Citation: SpringerPlus 2015 4:396

    Content type: Research

    Published on:

  8. To determine whether exercise training improves autonomic function in women with breast cancer (BC).

    Authors: Francesco Giallauria, Luigi Maresca, Alessandra Vitelli, Maria Santucci de Magistris, Paolo Chiodini, Amalia Mattiello, Marco Gentile, Maria Mancini, Alessandra Grieco, Angelo Russo, Rosa Lucci, Giorgio Torella, Franco Berrino, Salvatore Panico and Carlo Vigorito

    Citation: SpringerPlus 2015 4:388

    Content type: Research

    Published on:

  9. We investigated in postmenopausal women with primary breast cancer prior to surgical intervention whether, serum levels of different steroid hormones and hormonal precursors associated with tumor tissue estrog...

    Authors: Borbála Vincze, Bence Kapuvári, Nóra Udvarhelyi, Zsolt Horváth, Zoltán Mátrai, Ferenc Czeyda-Pommersheim, Krisztina Kőhalmy, Judit Kovács, Mariann Boldizsár, István Láng and Miklós Kásler

    Citation: SpringerPlus 2015 4:387

    Content type: Research

    Published on:

  10. Breast cancer subtype, determined by expression of estrogen/progesterone receptor (ER/PR) and human epidermal growth factor receptor (HER)-2, is predictive for prognosis. The importance of subtype to locoregio...

    Authors: Chi Zhang, Shuang Wang, Hayley P Israel, Sherry X Yan, David P Horowitz, Seth Crockford, Daniela Gidea-Addeo, K S Clifford Chao, Kevin Kalinsky and Eileen P Connolly

    Citation: SpringerPlus 2015 4:386

    Content type: Debate

    Published on:

  11. There is a significant difference in the mean tumor size between very young breast cancer patients and their elder counterparts. A simple comparison may show obvious prognostic differences. We investigated the...

    Authors: Masujiro Makita, Takehiko Sakai, Akemi Kataoka, Dai Kitagawa, Akiko Ogiya, Hidetomo Morizono, Yumi Miyagi, Kotaro Iijima, Kokoro Kobayashi, Takayuki Kobayashi, Ippei Fukada, Kazuhiro Araki, Shunji Takahashi, Yoshinori Ito, Naoya Gomi, Masahiko Oguchi…

    Citation: SpringerPlus 2015 4:365

    Content type: Research

    Published on:

  12. Mastectomy is effective treatment for ductal carcinoma in situ (DCIS) but some women will develop chest wall recurrence. Most chest wall recurrences that develop after mastectomy are invasive cancer and are as...

    Authors: Jonathan Klein, Iwa Kong, Lawrence Paszat, Sharon Nofech-Mozes, Wedad Hanna, Deva Thiruchelvam, Steven A. Narod, Refik Saskin, Susan J. Done, Naomi Miller, Bruce Youngson, Alan Tuck, Sandip Sengupta, Leela Elavathil, Prashant A. Jani, Elzbieta Slodkowska…

    Citation: SpringerPlus 2015 4:335

    Content type: Research

    Published on:

  13. Neoadjuvant chemotherapy (NCT) using anthracyclines and taxanes is a standard treatment for locally advanced breast cancer. Efficacy of NCT is however variable among patients and predictive markers are expecte...

    Authors: Aurélie Dumont, Diane Pannier, Agnès Ducoulombier, Emmanuelle Tresch, Jinying Chen, Andrew Kramar, Françoise Révillion, Jean-Philippe Peyrat and Jacques Bonneterre

    Citation: SpringerPlus 2015 4:327

    Content type: Research

    Published on:

  14. Pseudoangiomatous stromal hyperplasia (PASH) is a benign lesion often observed in parts of the mammary stroma in a variety of breast diseases. It is characterized by stromal myofibroblastic proliferation that ...

    Authors: Akiko Mizutou, Kazutaka Nakashima and Takuya Moriya

    Citation: SpringerPlus 2015 4:282

    Content type: Case study

    Published on:

  15. Although its unclear oncological risk, which led to more than 20 years of prohibition of its use, fat grafting to the breast is widely used nowadays even for aesthetic purposes. Thus, we proposed an experiment...

    Authors: Francisco Claro Jr., Joseane Morari, Luciana R Moreira, Luís O Z Sarian, Glauce A Pinto, Licio A Velloso and Aarão M Pinto-Neto

    Citation: SpringerPlus 2015 4:279

    Content type: Research

    Published on:

  16. The aim of our study was to look for alternative predictive biomarkers for breast cancer management in limited resource setup. A comprehensive analysis of circulating cell-free DNA (CCFD) in serum at baseline ...

    Authors: Sobuhi Iqbal, Sreenivas Vishnubhatla, Vinod Raina, Surabhi Sharma, Ajay Gogia, Suryanarayana S V Deo, Sandeep Mathur and Nutan Kumar Shukla

    Citation: SpringerPlus 2015 4:265

    Content type: Research

    Published on:

  17. We have developed a new approach to reduce the serum interference for ELISA. The purpose of this study is to investigate if we can use the optimized ELISA (MBB-ELISA) to detect serum soluble HER2/neu (sHER2) i...

    Authors: Julia Tchou, Lian Lam, Yun Rose Li, Claire Edwards, Bonnie Ky and Hongtao Zhang

    Citation: SpringerPlus 2015 4:237

    Content type: Short report

    Published on:

  18. Bilateral Breast Carcinoma (BBC) is a rare entity with incidence of synchronous carcinoma being 2-5% of all breast malignancies, which is much less than metachronous carcinoma. Synchronicity/ metachronicity ar...

    Authors: Vijay Kumar Shankarrao Kappikeri and Akshay Mahesh Kriplani

    Citation: SpringerPlus 2015 4:193

    Content type: Case study

    Published on:

  19. Yoga-based exercise has proven to be beneficial for practitioners, including cancer survivors. This study reports on the effect on inflammatory biological markers for 20 breast cancer survivors who participate...

    Authors: Dorothy Long Parma, Daniel C Hughes, Sagar Ghosh, Rong Li, Rose A Treviño-Whitaker, Susan M Ogden and Amelie G Ramirez

    Citation: SpringerPlus 2015 4:143

    Content type: Research

    Published on:

  20. Primary small cell carcinomas of the breast (SCCB) are rare tumors with limited data on outcomes and treatment strategies. Using a population based approach, we aimed to study outcomes of SCCB and determine wh...

    Authors: Felicia Hare, Smith Giri, Jashmin K Patel, Andrew Hahn and Michael G Martin

    Citation: SpringerPlus 2015 4:138

    Content type: Research

    Published on:

  21. Breast cancer is the most common malignancy among women. Surgical treatment is an essential part of therapy, which still includes chemotherapy, radiotherapy and hormone therapy. The increase in early cancer de...

    Authors: Kassandra Ferreira Pessoa Fukushima, Luana Aroucha Carmo, Adriana Carvalho Borinelli and Caroline Wanderley Souto Ferreira

    Citation: SpringerPlus 2015 4:112

    Content type: Research

    Published on:

  22. Majority of the known breast cancer susceptibility genes have a role in DNA repair and the most important high-risk genes BRCA1 and BRCA2 are specifically involved in the homologous recombination repair (HRR) of ...

    Authors: Liisa M Pelttari, Johanna I Kiiski, Salla Ranta, Sara Vilske, Carl Blomqvist, Kristiina Aittomäki and Heli Nevanlinna

    Citation: SpringerPlus 2015 4:92

    Content type: Research

    Published on:

  23. The high expense of newer, more effective adjuvant endocrine therapy agents (aromatase inhibitors [AIs]) for postmenopausal breast cancer contributes to socioeconomic disparities in breast cancer outcomes. Thi...

    Authors: Ann Butler Nattinger, Liliana E Pezzin, Emily L McGinley, John A Charlson, Tina W F Yen and Joan M Neuner

    Citation: SpringerPlus 2015 4:54

    Content type: Research

    Published on:

    The Erratum to this article has been published in SpringerPlus 2015 4:531

  24. The cell-cycle checkpoint kinase 2 (CHEK2) is an important signal transducer of cellular responses to DNA damage, whose defects has been associated with increased risk for breast cancer. The CHEK2 1100delC mut...

    Authors: Chaymaa Marouf, Omar Hajji, Brehima Diakité, Amal Tazzite, Hassan Jouhadi, Abdellatif Benider and Sellama Nadifi

    Citation: SpringerPlus 2015 4:38

    Content type: Research

    Published on:

  25. Clinicians have traditionally used clinicopathological (CP) factors to determine locoregional recurrence (LR) risk of breast cancer and have generated the IBTR! nomogram to predict the risk of ipsilateral brea...

    Authors: Nikhil G Thaker, Karen E Hoffman, Michael C Stauder, Simona F Shaitelman, Eric A Strom, Welela Tereffe, Benjamin D Smith, George H Perkins, Lei Huo, Mark F Munsell, Lajos Pusztai, Thomas A Buchholz and Wendy A Woodward

    Citation: SpringerPlus 2015 4:36

    Content type: Research

    Published on:

  26. Doxorubicin (DOX) chemotherapy can cause cardiac complications. Angiotensin converting enzyme inhibitors (ACEI) may protect against these complications. We performed a pharmacokinetics (PK) study to determine ...

    Authors: Anne Blaes, Daniel Duprez, Todd Defor, Ryan Shanley, Heather Beckwith, Tufia Haddad, David Potter, Douglas Yee, Kinjal Sanghavi and Pamala Jacobson

    Citation: SpringerPlus 2015 4:32

    Content type: Research

    Published on:

  27. Invasive breast carcinoma is the most common cancer in women as in non-ovariectomised pet dogs, which are already identified as a valuable spontaneous preclinical model for that disease. Geographical and time ...

    Authors: Sabine Sévère, Philippe Marchand, Ingrid Guiffard, Floriane Morio, Anaïs Venisseau, Bruno Veyrand, Bruno Le Bizec, Jean-Philippe Antignac and Jérôme Abadie

    Citation: SpringerPlus 2015 4:27

    Content type: Research

    Published on:

  28. Considerable debate exists about the optimal treatment of ductal carcinoma in situ (DCIS). Using electronic data sources, we examined first course treatment patterns among women aged 18 years and older diagnosed ...

    Authors: Heather Spencer Feigelson, Nikki M Carroll, Sheila Weinmann, Reina Haque, Chu-Ling Yu, Melissa G Butler, Beth Waitzfelder, Michelle G Wrenn, Angela Capra, Elizabeth A McGlynn and Laurel A Habel

    Citation: SpringerPlus 2015 4:24

    Content type: Research

    Published on:

  29. To determine whether capecitabine (X), combined with docetaxel (T) following doxorubicin (A) and cyclophosphamide (C), enhanced the pathological complete response (pCR) in the breast and axillary lymph nodes (...

    Authors: Jennifer Eremin, Ged Cowley, Leslie G Walker, Elisabeth Murray, Monika Stovickova and Oleg Eremin

    Citation: SpringerPlus 2015 4:9

    Content type: Research

    Published on:

  30. This study was conducted in order to investigate the implications of the R72P polymorphism in the TP53 gene in breast cancer risk. The enlightenment of this matter might provide a piece of information about the p...

    Authors: Meire Luzia Gonçalves, Sarah Moreira Borja, Jacqueline Andréia Bernardes Leão Cordeiro, Vera Aparecida Saddi, Flávio Monteiro Ayres, Cesar Augusto Sam Tiago Vilanova-Costa and Antonio Márcio Teodoro Cordeiro Silva

    Citation: SpringerPlus 2014 3:749

    Content type: Research

    Published on:

  31. Familial breast and ovarian cancer prevalence was assessed among 1150 women of Mexican descent enrolled in a case-only, binational breast cancer study. Logistic regression was conducted to compare odds of trip...

    Authors: Kristin Anderson, Patricia A Thompson, Betsy C Wertheim, Lorena Martin, Ian K Komenaka, Melissa Bondy, Adrian Daneri-Navarro, Maria Mercedes Meza-Montenegro, Luis Enrique Gutierrez-Millan, Abenaa Brewster, Lisa Madlensky, Malaika Tobias, Loki Natarajan and María Elena Martínez

    Citation: SpringerPlus 2014 3:727

    Content type: Research

    Published on:

  32. In recent years, circulating miRNAs have attracted interest as stable, non-invasive biomarkers for various pathological conditions. Here, we investigated their potential to serve as minimally invasive, early d...

    Authors: Khouloud Hamdi, David Goerlitz, Neila Stambouli, Mohammed Islam, Olfa Baroudi, Bilel Neili, Farhat Benayed, Simon Chivi, Christopher Loffredo, Irene A Jillson, Amel Benammar Elgaaied, Jan K Blancato and Raja Marrakchi

    Citation: SpringerPlus 2014 3:636

    Content type: Research

    Published on:

  33. Here we investigate the feasibility of tumor metabolism monitoring in T1c to T3 breast cancer during neoadjuvant chemotherapy by means of phosphorus (31P) magnetic resonance spectroscopy at 7 tesla (T). Five brea...

    Authors: Wybe JM van der Kemp, Bertine L Stehouwer, Peter R Luijten, Maurice AAJ van den Bosch and Dennis WJ Klomp

    Citation: SpringerPlus 2014 3:634

    Content type: Research

    Published on:

  34. This paper investigates the distribution of age at diagnosis of female breast cancer and its association with temporal trend, clinicopathologic and sociodemographic variables in the presence of two latent clus...

    Authors: Gabriel Escarela, Luis Carlos Pérez-Ruiz and Gabriel Núñez-Antonio

    Citation: SpringerPlus 2014 3:626

    Content type: Research

    Published on:

  35. The humanized monoclonal antibody trastuzumab has been in routine use for chemotherapy for human epidermal growth factor receptor II (HER2)-positive breast cancer. A major adverse effect of trastuzumab is card...

    Authors: Kenichi Katsurada, Masaru Ichida, Masako Sakuragi, Megumi Takehara, Yasuo Hozumi and Kazuomi Kario

    Citation: SpringerPlus 2014 3:620

    Content type: Research

    Published on:

  36. While de-escalation of bisphosphonates from 4 to 12-weekly dosing has been shown to be clinically non-inferior to standard dosing, there is evidence the de-escalation is associated with increased bone turnover...

    Authors: Christina L Addison, Gregory R Pond, Huijun Zhao, Sasha Mazzarello, Lisa Vandermeer, Robyn Goldstein, Eitan Amir and Mark Clemons

    Citation: SpringerPlus 2014 3:577

    Content type: Research

    Published on:

  37. Triple negative breast cancer (TNBC) constitutes 10-15% of female breast cancers, and clinical guidelines recommend treatment with chemotherapy and surgery. We examined the recorded treatment and survival of w...

    Authors: Shrestha Pal, Margreet Lüchtenborg, Elizabeth A. Davies and Ruth H. Jack

    Citation: SpringerPlus 2014 3:553

    Content type: Research

    Published on:

  38. 18,000 women die due to metastatic breast cancer in Germany per year. Median survival is 20–28 months after diagnosis. The question we wanted to answer was whether survival has improved in routine care? For th...

    Authors: Rudolf Weide, Stefan Feiten, Vera Friesenhahn, Jochen Heymanns, Kristina Kleboth, Jörg Thomalla, Christoph van Roye and Hubert Köppler

    Citation: SpringerPlus 2014 3:535

    Content type: Research

    Published on:

  39. We hypothesized that improved acute postoperative pain relief will be achieved using general anaesthesia (GA) either in combination with continuous thoracic paravertebral block (GA-cPVB) or single shot (GA-sPV...

    Authors: Esther A C Bouman, Maurice Theunissen, Alfons GH Kessels, Kristien BMI Keymeulen, Elbert AJ Joosten, Marco AE Marcus, Wolfgang F Buhre and Hans-Fritz Gramke

    Citation: SpringerPlus 2014 3:517

    Content type: Research

    Published on:

  40. Scalp cooling is a long known method to reduce chemotherapy-induced alopecia in cancer patients with solid tumors. Due to a progress in this method, a medical device enabling individual feedback-controlled tem...

    Authors: Kay Friedrichs and Martin H Carstensen

    Citation: SpringerPlus 2014 3:500

    Content type: Short report

    Published on:

  41. Subsequent to chemotherapy treatment, breast cancer patients often report a decline in cognitive functioning that can adversely impact many aspects of their lives. Evidence has mounted in recent years indicati...

    Authors: Chris Lepage, Andra M Smith, Jeremy Moreau, Emily Barlow-Krelina, Nancy Wallis, Barbara Collins, Joyce MacKenzie and Carole Scherling

    Citation: SpringerPlus 2014 3:444

    Content type: Research

    Published on:

  42. Triple-negative breast cancer (TNBC) is associated with a higher incidence of recurrence and distant metastasis and a poor prognosis, whereas effective treatment strategies remain to be established. Finding an...

    Authors: Masato Terashima, Kazuko Sakai, Yosuke Togashi, Hidetoshi Hayashi, Marco A De Velasco, Junji Tsurutani and Kazuto Nishio

    Citation: SpringerPlus 2014 3:417

    Content type: Research

    Published on:

  43. Racial disparities in breast reconstruction for breast cancer are documented. Place of service has contributed to disparities in cancer care; but the interaction of race/ethnicity and place of service has not ...

    Authors: Tracy Onega, Julie Weiss, Karla Kerlikowske, Karen Wernli, Diana SM Buist, Louise M Henderson, Martha Goodrich, Jennifer Alford-Teaster, Beth Virnig, Anna NA Tosteson, Wendy DeMartini and Rebecca Hubbard

    Citation: SpringerPlus 2014 3:416

    Content type: Research

    Published on:

  44. Identifying ductal carcinoma in situ (DCIS) patients at highest risk for recurrence after breast conserving surgery (BCS) remains a clinical concern. Subjecting all such patients to radiotherapy may be unneces...

    Authors: Taeryung Kim, Heung Kyu Park, Kyung Hee Lee, Kwan Il Kim, Kyu Chan Lee, Jeong Suk Ahn and Kwang-Pil Ko

    Citation: SpringerPlus 2014 3:405

    Content type: Research

    Published on:

  45. It is a well-established multidisciplinary practice at the European Institute of Oncology, that nurses and physicians often report their difficulties to clinical psychologists regarding adherence to hospital s...

    Authors: Paola Arnaboldi, Claudio Lucchiari, Luigi Santoro, Claudia Sangalli, Alberto Luini and Gabriella Pravettoni

    Citation: SpringerPlus 2014 3:392

    Content type: Research

    Published on: